Literature DB >> 25327504

Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.

Hye Jung Park1, Sung Ryeol Kim, Dong Woo Leem, Il Joo Moon, Beom Seok Koh, Kyung Hee Park, Jung-Won Park, Jae-Hyun Lee.   

Abstract

PURPOSE: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but fatal adverse mucocutaneous reactions to certain drugs. Recent studies suggest that ethnicity and genetic predisposition may play a crucial role in the manifestation of the reaction. In this study, we described the role of human leukocyte antigen (HLA)-B alleles in the development of clinical characteristics and treatment outcomes of SJS/TEN in a single Korean tertiary hospital.
METHODS: We retrospectively reviewed the medical records (from March 1, 2010 to February 28, 2014) of 30 patients diagnosed with SJS and/or TEN.
RESULTS: The main causative drugs were anticonvulsants (26.7 %) and allopurinol (26.7 %), followed by antibiotics (16.7 %), acetazolamide (10.0 %), acetaminophen (10.0 %), and herbal medication (6.7 %). The mean latencies of these drugs were variable. Liver damage was the most common symptom (observed in 63.3 % of the patients). Of the five patients with lamotrigine-induced SJS/TEN, three expressed the HLA-B*4403 allele (60.0 %). Of the seven patients with allopurinol-induced SJS/TEN, five expressed the HLA-B*5801 allele (71.4 %).
CONCLUSIONS: The major SJS/TEN-inducing drugs were found to be allopurinol and anticonvulsants (such as lamotrigine). We speculated that Korean individuals expressing the HLA-B*4403 allele may be highly susceptible to lamotrigine-induced SJS/TEN.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25327504     DOI: 10.1007/s00228-014-1764-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  40 in total

1.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  HLA typing using bead-based methods.

Authors:  Daniel Trajanoski; Samantha J Fidler
Journal:  Methods Mol Biol       Date:  2012

3.  HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Authors:  Nahoko Kaniwa; Yoshiro Saito; Michiko Aihara; Kayoko Matsunaga; Masahiro Tohkin; Kouichi Kurose; Hirokazu Furuya; Yukitoshi Takahashi; Masaaki Muramatsu; Shigeru Kinoshita; Masamichi Abe; Hiroko Ikeda; Mariko Kashiwagi; Yixuan Song; Mayumi Ueta; Chie Sotozono; Zenro Ikezawa; Ryuichi Hasegawa
Journal:  Epilepsia       Date:  2010-11-03       Impact factor: 5.864

4.  SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center.

Authors:  Rob Cartotto; Mike Mayich; Duncan Nickerson; Manuel Gomez
Journal:  J Burn Care Res       Date:  2008 Jan-Feb       Impact factor: 1.845

5.  Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system.

Authors:  H Askmark; B E Wiholm
Journal:  Acta Neurol Scand       Date:  1990-02       Impact factor: 3.209

6.  Epidemiological study of severe cutaneous adverse drug reactions in a city district of China.

Authors:  L-F Li; C Ma
Journal:  Clin Exp Dermatol       Date:  2006-09       Impact factor: 3.470

7.  Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.

Authors:  Choong-Chor Chang; Chun-Lai Too; Shahnaz Murad; Suraiya Hani Hussein
Journal:  Int J Dermatol       Date:  2011-02       Impact factor: 2.736

8.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Authors:  Ariane Auquier-Dunant; Maja Mockenhaupt; Luigi Naldi; Osvaldo Correia; Werner Schröder; Jean-Claude Roujeau
Journal:  Arch Dermatol       Date:  2002-08

Review 9.  Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Andrea T Borchers; Jennifer L Lee; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2008-07-09       Impact factor: 9.754

10.  Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients.

Authors:  Mariko Kashiwagi; Michiko Aihara; Yukitoshi Takahashi; Etsuko Yamazaki; Yumiko Yamane; Yixuan Song; Masaaki Muramatsu; Zenro Ikezawa
Journal:  J Dermatol       Date:  2008-10       Impact factor: 4.005

View more
  7 in total

1.  The Immunogenetics of Cutaneous Drug Reactions.

Authors:  Neda Khalili
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.

Authors:  Bénédicte Lebrun-Vignes; Claire Guy; Marie-Josèphe Jean-Pastor; Valérie Gras-Champel; Marie Zenut
Journal:  Br J Clin Pharmacol       Date:  2017-11-10       Impact factor: 4.335

Review 3.  Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.

Authors:  Kalliopi Gerogianni; Aspasia Tsezou; Konstantinos Dimas
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.476

4.  Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population.

Authors:  Napatrupron Koomdee; Jirawat Pratoomwun; Thawinee Jantararoungtong; Voralaksana Theeramoke; Wichittra Tassaneeyakul; Jettanong Klaewsongkram; Ticha Rerkpattanapipat; Siwalee Santon; Apichaya Puangpetch; Utcharee Intusoma; Therdpong Tempark; Tayard Deesudchit; Patompong Satapornpong; Anannit Visudtibhan; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2017-11-29       Impact factor: 5.810

5.  Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials.

Authors:  Romi Bloom; Kyle T Amber
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

Review 6.  Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions.

Authors:  Ali Fadhel Ahmed; Chonlaphat Sukasem; Majeed Arsheed Sabbah; Nur Fadhlina Musa; Dzul Azri Mohamed Noor; Nur Aizati Athirah Daud
Journal:  J Pers Med       Date:  2021-05-07

7.  HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.

Authors:  Hye Jung Park; Young Joo Kim; Dong Hyun Kim; Junho Kim; Kyung Hee Park; Jung Won Park; Jae Hyun Lee
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.